|
DSpace at RU >
University Library >
Academic bibliography >
Files in This Item:
| File |
Description |
Size | Format |
|---|
 | publisher's version | 317.19 kB | Adobe PDF | Under Embargo
|
|
| Title: | Dendritic cell immunotherapy: mapping the way. |
| Author(s): | Figdor, C.G. (067631614)
Vries, I.J.M. de (162370016)
Lesterhuis, W.J. (298208342)
Melief, C.J. |
| Publication year: | 2004 |
| Document type: | Article / Letter to editor |
| Journal: | Nature Medicine |
| ISSN: | 1078-8956 |
| Volume: | vol. 10 |
| Issue: | iss. 5 |
| Start page: | p. 475 |
| End page: | p. 480 |
| Abstract: | Dendritic cells (DCs) are the professional antigen-presenting cells of the immune system, with the potential to either stimulate or inhibit immune responses. Exploiting the immune-regulatory capacities of dendritic cells holds great promise for the treatment of cancer, autoimmune diseases and the prevention of transplant rejection. Although early clinical trials indicate that DC vaccines can induce immune responses in some cancer patients, careful study design and use of standardized clinical and immunological criteria are needed. |
| Subject: | UMCN 1.4: Immunotherapy, gene therapy and transplantation |
| Organization: | Tumorimmunology
Medical Oncology
UMCN Extern |
| Appears in Collections: | Academic bibliography
|
|
Please use this identifier to cite or link to this item:
http://hdl.handle.net/2066/57974
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|
|
